Rosalind Advisors, Inc. - 30 Oct 2024 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DCTH	Tranche B warrants to purchase F-4 Preferred Stock	Options Exercise	$500,000	+500		$1000.00	0	30 Oct 2024	F-4 PREFERRED STOCK	500	$1000.00	By Rosalind Advisors, Inc., the advisor to the Rosalind Funds	F1, F2, F3
transaction	DCTH	8% CONVERTIBLE NOTE	Expiration (or cancellation) of long derivative position with value received	$0	0		$0.000000	0	30 Oct 2024	CASH	$1,423,333	$0.000000	By Rosalind Advisors, Inc., the advisor to the Rosalind Funds	F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Immediately exercisable
F2	The Tranche B Warrants expire the earlier of (i) twenty-one (21) days following the date of the Issuer's public announcement of record at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and (ii) March 31, 2026. The Issuer announced on October 17, 2024 that it had recorded at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and therefore such Tranche B Warrants expire on November 7, 2024.
F3	Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein
F4	Delcath repaid the DELCATH SYSTEM - 8% CONVERTIBLE NOTE in full with cash of $1,423,333.
F5	N/A